Naproxen Accord

Naproxen, the active ingredient in Naproxen Accord, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats pain, fever and inflammation in adults. GNH USA supplies Naproxen Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen is an NSAID that reduces inflammation and pain across several musculoskeletal and systemic conditions. - Pain: provides relief of mild to moderate acute pain. - Fever: lowers elevated body temperature associated with infection or inflammation. - Osteoarthritis: improves joint function and reduces chronic joint pain. - Rheumatoid arthritis: diminishes inflammatory swelling and stiffness. - Dysmenorrhea: alleviates menstrual cramps and associated discomfort. - Inflammation: decreases swelling in various inflammatory disorders.

Adverse reactions may vary in frequency and severity. Patients should be informed of both common and less frequent but serious events.

Common Side Effects: - Gastrointestinal upset: dyspepsia, nausea, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: transient episodes of light‑headedness. - Rash: mild skin erythema or pruritus. - Edema: peripheral swelling, especially of the ankles. - Elevated liver enzymes: mild, transient increases.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Cardiovascular events: myocardial infarction or stroke. - Renal impairment: acute kidney injury or reduced renal function. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic failure: marked liver enzyme elevation with jaundice. - Anaphylaxis: rare systemic allergic response.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and follow safe handling practices. - Assess gastrointestinal risk: review history of ulcers, bleeding, or chronic NSAID use. - Evaluate cardiovascular status: consider existing heart disease or risk factors. - Monitor renal function: check baseline creatinine in patients with kidney disease. - Use lowest effective dose: limit duration to the shortest period needed for symptom control. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and direct sunlight.

Naproxen may alter the pharmacologic profile of several co‑administered medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency. - Lithium: naproxen can raise lithium serum concentrations.

Moderate Interactions (Monitor Closely): - Diuretics: may reduce renal clearance of naproxen. - ACE inhibitors or ARBs: potential for reduced renal function. - Methotrexate: naproxen can decrease methotrexate elimination. - Corticosteroids: combined use raises ulcer risk.